With $126M IPO, Precision aims to bring allogeneic CAR T to clinic this half

Precision raised $126.4 million Wednesday in a NASDAQ IPO that values the gene editing company at about $784.5 million.

Precision BioSciences Inc. (NASDAQ:DTIL) sold 7.9 million shares at $16, the midpoint of its proposed range. It will begin trading Thursday...